• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)对有无糖尿病的无症状个体亚临床冠状动脉粥样硬化的不同影响。

Differential impact of lipoprotein(a) on subclinical coronary atherosclerosis in asymptomatic individuals with and without diabetes mellitus.

作者信息

Jang Mi-Hee, Park Sangwoo, Ann Soe Hee, Kim Yong-Giun, Jeon Young-Jee, Lim Soyeoun, Kwon Woon Jung, Choi Seong Hoon, Han Seungbong, Park Gyung-Min

机构信息

Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, 25, Daehakbyeongwon-ro, Dong-gu, Ulsan, 44033, Republic of Korea.

Department of Family Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

出版信息

Sci Rep. 2025 Jul 1;15(1):20436. doi: 10.1038/s41598-025-04964-8.

DOI:10.1038/s41598-025-04964-8
PMID:40593975
Abstract

The relationship between subclinical coronary atherosclerosis and lipoprotein(a) (Lp[a]) in asymptomatic people with and without diabetes mellitus (DM) is not well understood. We conducted a retrospective analysis of 7201 asymptomatic people (average age 54.4 ± 7.9 years; 65.3% male) who voluntarily had coronary computed tomography angiography (CCTA) as part of a general health evaluation and had no history of coronary artery disease (CAD). The severity and extent of subclinical coronary atherosclerosis were assessed using CCTA, with obstructive CAD defined as a diameter stenosis of at least 50%. Based on their Lp(a) levels, the study participants were divided into tertiles. To assess the relationship between Lp(a) levels and subclinical coronary atherosclerosis, logistic regression analysis was used. In participants without DM (n = 6252), after adjusting for cardiovascular risk factors, there were no statistically significant differences in the adjusted odds ratios (ORs) for calcified plaque, mixed plaque, non-calcified plaque, and obstructive CAD in the third Lp(a) tertile compared to the first tertile (p > 0.05 for all). On the other hand, in participants with DM (n = 949), there were no statistically significant differences in the ORs for calcified plaque (1.117, 95% confidence interval [CI] 0.794-1.572), mixed plaque (1.552, 95% CI 0.888-2.714), or non-calcified plaque (1.735, 95% CI 0.980-3.072) between the first and third Lp(a) tertiles. However, the adjusted ORs for obstructive CAD (2.051, 95% CI 1.248-3.372) were significantly higher in the third Lp(a) tertile compared to the first Lp(a) tertile. In asymptomatic individuals with DM, higher Lp(a) levels were associated with obstructive CAD, which may be linked to an increased risk of cardiac events.

摘要

在无症状的糖尿病患者和非糖尿病患者中,亚临床冠状动脉粥样硬化与脂蛋白(a)[Lp(a)]之间的关系尚未完全明确。我们对7201名无症状者(平均年龄54.4±7.9岁;65.3%为男性)进行了一项回顾性分析,这些人自愿接受冠状动脉计算机断层扫描血管造影(CCTA)作为一般健康评估的一部分,且无冠状动脉疾病(CAD)病史。使用CCTA评估亚临床冠状动脉粥样硬化的严重程度和范围,阻塞性CAD定义为直径狭窄至少50%。根据Lp(a)水平,将研究参与者分为三分位数。为了评估Lp(a)水平与亚临床冠状动脉粥样硬化之间的关系,采用了逻辑回归分析。在无糖尿病的参与者(n=6252)中,在调整心血管危险因素后,与第一个Lp(a)三分位数相比,第三个Lp(a)三分位数在钙化斑块、混合斑块、非钙化斑块和阻塞性CAD的调整优势比(OR)方面无统计学显著差异(所有p>0.05)。另一方面,在糖尿病患者(n=949)中,第一个和第三个Lp(a)三分位数在钙化斑块(1.117,95%置信区间[CI]0.794-1.572)、混合斑块(1.552,95%CI0.888-2.714)或非钙化斑块(1.735,95%CI0.980-3.072)的OR方面无统计学显著差异。然而,与第一个Lp(a)三分位数相比,第三个Lp(a)三分位数的阻塞性CAD调整OR(2.051,95%CI1.248-3.372)显著更高。在无症状的糖尿病个体中,较高的Lp(a)水平与阻塞性CAD相关,这可能与心脏事件风险增加有关。

相似文献

1
Differential impact of lipoprotein(a) on subclinical coronary atherosclerosis in asymptomatic individuals with and without diabetes mellitus.脂蛋白(a)对有无糖尿病的无症状个体亚临床冠状动脉粥样硬化的不同影响。
Sci Rep. 2025 Jul 1;15(1):20436. doi: 10.1038/s41598-025-04964-8.
2
Predictive value of coronary computed tomography angiography in asymptomatic individuals with diabetes mellitus: Systematic review and meta-analysis.冠状动脉计算机断层血管造影在无症状糖尿病患者中的预测价值:系统评价和荟萃分析。
J Cardiovasc Comput Tomogr. 2018 Jul-Aug;12(4):320-328. doi: 10.1016/j.jcct.2018.04.002. Epub 2018 Apr 12.
3
Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.基因预测的脂蛋白(a)与冠状动脉斑块严重程度相关,独立于低密度脂蛋白胆固醇。
Eur J Prev Cardiol. 2025 Jan 27;32(2):116-127. doi: 10.1093/eurjpc/zwae271.
4
The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.计算机断层扫描筛查冠心病的有效性和成本效益:系统评价
Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. doi: 10.3310/hta10390.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.洗必泰漱口水作为牙龈健康的辅助治疗方法。
Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD008676. doi: 10.1002/14651858.CD008676.pub2.
9
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南
Eur Heart J. 2023 Oct 14;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192.
2
The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials.PCSK9 抑制剂在糖尿病患者主要心血管事件和血脂谱中的疗效:随机对照试验的系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):318-327. doi: 10.1093/ehjcvp/pvad019.
3
Ten-year prognostic value of coronary CT angiography in asymptomatic patients with type 2 diabetes.
冠状动脉 CT 血管造影在 2 型糖尿病无症状患者中的 10 年预后价值。
Rev Esp Cardiol (Engl Ed). 2023 Sep;76(9):700-707. doi: 10.1016/j.rec.2023.01.004. Epub 2023 Jan 28.
4
Lipoprotein(a) is associated with coronary atheroma progression: analysis from a serial coronary computed tomography angiography study.脂蛋白(a)与冠状动脉粥样硬化进展相关:一项冠状动脉计算机断层扫描血管造影系列研究的分析
J Geriatr Cardiol. 2021 Dec 28;18(12):996-1007. doi: 10.11909/j.issn.1671-5411.2021.12.001.
5
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression.载脂蛋白(a)与动脉粥样硬化斑块进展的关系。
J Am Coll Cardiol. 2022 Jan 25;79(3):223-233. doi: 10.1016/j.jacc.2021.10.044.
6
Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.脂蛋白(a)与无症状个体亚临床冠状动脉粥样硬化。
Atherosclerosis. 2022 May;349:190-195. doi: 10.1016/j.atherosclerosis.2021.09.027. Epub 2021 Sep 28.
7
Cholesterol Control for Subclinical Coronary Atherosclerosis in Subjects Without Indication for Statin Therapy.无他汀类药物治疗适应证的亚临床冠状动脉粥样硬化患者的胆固醇控制。
Am J Cardiol. 2021 Aug 15;153:51-57. doi: 10.1016/j.amjcard.2021.05.019. Epub 2021 Jun 24.
8
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.优先考虑主要脂蛋白及其亚组份在周围动脉疾病风险因素中的作用。
Circulation. 2021 Aug 3;144(5):353-364. doi: 10.1161/CIRCULATIONAHA.121.053797. Epub 2021 Jun 18.
9
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
10
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.依洛尤单抗对急性冠状动脉综合征后脂蛋白(a)和心血管风险的影响。
J Am Coll Cardiol. 2020 Jan 21;75(2):133-144. doi: 10.1016/j.jacc.2019.10.057.